Business Context and Reporting Period
Company: Varex Imaging Corporation (VREX)
Filing Type: Form 8-K (Current Report)
Date of Report: March 13, 2026
Reporting Period: Events occurring on March 13, 2026, with a redemption date of March 16, 2026.
Key Financial Metrics and Capital Structure Changes
This filing details a significant refinancing transaction rather than operational financial results. Key metrics include:
- New Debt Facilities (Credit Agreement):
- Secured Term Loan: $350,000,000 (fully drawn on March 13, 2026).
- Secured Revolving Credit Facility: $100,000,000 (includes $35M letter of credit sub-facility and $20M swingline sub-facility).
- Secured Delayed Draw Term Loan: $40,000,000.
- Total New Facility Capacity: $490,000,000.
- Maturity Date: March 13, 2031.
- Debt Repayment:
- Redemption of 2027 Notes: $368,000,000 aggregate principal amount (7.875% Senior Secured Notes due 2027).
- Funding Source: Proceeds from the new $350M term loan plus cash on hand.
- Terminated Facility:
- Previous Revolving Credit Agreement (dated March 26, 2024): Up to $155,000,000.
- Outstanding Balance at Termination: $0.
- Interest Rate Basis: SOFR plus a margin or alternative base rate plus a margin, priced based on a consolidated total net leverage ratio grid.
Material Changes Versus Prior Period
The filing represents a material restructuring of the Company's debt profile:
- Debt Extension: The Company extended its debt maturity from 2027 (2027 Notes) and 2027 (Terminated Credit Agreement) to 2031 under the new Credit Facility.
- Interest Rate Environment: Transitioned from a fixed 7.875% coupon on the 2027 Notes to a floating rate structure (SOFR or Base Rate) with a leverage-based margin.
- Liquidity Position: Increased available liquidity by replacing a fully utilized or matured facility structure with a new $100M revolving facility and a $40M delayed draw term loan, while retiring $368M in fixed-rate debt.
- Covenant Structure: Adopted new affirmative and negative covenants, including limitations on additional indebtedness, liens, and restricted payments, replacing the terms of the 2027 Notes Indenture and the Terminated Credit Agreement.
Guidance, Outlook, and Risks
Management Commentary and Use of Proceeds: The proceeds from the new term loan, combined with existing cash, were utilized to fund the redemption of the 2027 Notes and associated expenses. The new revolving facility is designated for working capital and general corporate purposes.
Risks and Contingencies:
- Events of Default: The new Credit Agreement includes standard events of default (non-payment, bankruptcy, covenant breach, change of control). An event of default could trigger acceleration of obligations and termination of commitments.
- Financial Maintenance: The agreement contains customary financial maintenance provisions tied to the Company's leverage ratio.
- Collateralization: Obligations are secured by guarantees from domestic and international subsidiaries and collateral.
Outlook: The filing does not provide specific operational guidance or revenue forecasts. The strategic outlook focuses on debt maturity extension and liquidity management.
Investor Verification Checklist
- Verify the specific interest rate margins and leverage ratio grid tiers in the full Credit Agreement (Exhibit 10.1).
- Confirm the exact redemption price paid for the 2027 Notes (including any make-whole premiums or accrued interest) to assess the total cost of refinancing.
- Review the specific financial maintenance covenants to understand the Company's ongoing compliance requirements.
- Assess the impact of the transition from fixed-rate to floating-rate debt on future interest expense volatility.
- Check for any prepayment penalties or fees associated with the new Credit Facility.